Skip to main content
Premium Trial:

Request an Annual Quote

Genomas Lands $1.4M SBIR Grant

NEW YORK (GenomeWeb News) – Genomas has won a $1.4 million grant from the National Institutes of Health to develop pharmacogenomic technology that will help doctors predict drug efficacy and side-effect risk for neuropsychiatric disease patients.

The company plans to use the Small Business Innovation Research grant to continue developing its PhyzioType Systems, which use genetic polymorphisms found through array genotyping and an algorithm to help doctors develop personalized drug prescriptions for antidepressants and antipsychotics.

The research program integrates Genomas' physiogenomics technology with fMRI research developed at Hartford Hospital's Institute of Living and neuro-informatics studies conducted at the Mind Research Network and the University of New Mexico.

The technology "will open significant new avenues for interdisciplinary translational research and commercial strategic partnering in clinical neuroscience," Gualberto Ruano, Genomas' CEO and president and director of genetics research at Hartford Hospital, said in a statement.

Genomas, which is based on the campus of Hartford Hospital, has now secured a total of $4.8 million in NIH funding to develop the PhyzioType.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.